Αποτελέσματα Αναζήτησης
The GOLD 2018 document states that the treatment goals for COPD are symptom reduction (including improved exercise capacity and overall health status) as well as risk reduction for adverse outcomes (symptom progression, exacerbations, and mortality).
19 Νοε 2021 · This paper provides new insights into the potential therapeutic effects of vitamin E on COPD. The authors show that vitamin E relieves chronic obstructive pulmonary disease (COPD)...
28 Ιαν 2021 · Pharmacologic treatment options are used to reduce symptoms, to improve health status and exercise tolerance, and to reduce COPD exacerbation risk. 6, 23, 24 Patients are assigned initial maintenance therapy based on symptom burden, exacerbation history, and treatment goals.
10 Αυγ 2023 · Some research has shown that high-dose vitamin E might delay the progression of Alzheimer's disease in people who have been diagnosed with mild to moderate Alzheimer's disease. Other studies haven't shown this benefit. Vitamin E supplements appear to have no effect on whether people with mild cognitive impairment progress to Alzheimer's disease.
The present study shows that vitamin E inhibits the expression of COX2 by negatively regulating the EGFR/MAPK pathway, thereby inhibiting the translocation of phosphorylated STAT3 to the nucleus and relieving COPD.
24 Νοε 2021 · Taking into account the variety of antioxidant options available, the objective of this scoping review was to determine the effect of the use of antioxidants in the treatment of COPD patients and the decrease in the likelihood of exacerbations, hospital readmissions, and lung function parameters.
31 Μαΐ 2021 · Chronic inflammation contributes to the onset and progression of the disease and furthers the risk of comorbidities. Current treatment options and prevention strategies for COPD are very limited. Tocotrienols are a group of vitamin E molecules with antioxidant and anti-inflammatory properties.
